Abstract
Forty patients with Parkinsonism and heart disease were studied before and during the administration of levodopa. Patients with increasing angina, myocardial infarction within the previous year, pre-existing severe postural hypotension, or transient cerebral ischaemia were excluded. Thirty-eight patients showed no adverse effects; angina improved in one patient but later worsened; one patient died of myocardial infarction after a severe gastrointestinal haemorrhage. Therapy with levodopa appears to pose little increased hazard to patients with most forms of heart disease. Inpatient monitoring is recommended at the beginning of therapy, and antiarrhythmic agents should be used when required.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Calne D. B., Stern G. M., Spiers A. S., Laurence D. R. L-dopa in idiopathic parkinsonism. Lancet. 1969 Nov 8;2(7628):973–976. doi: 10.1016/s0140-6736(69)90536-4. [DOI] [PubMed] [Google Scholar]
- Freemon F. R. Parkinsonism and cardiac arrhythmias. Lancet. 1971 Jan 9;1(7689):83–84. doi: 10.1016/s0140-6736(71)90811-7. [DOI] [PubMed] [Google Scholar]
- Goldberg L. I., Whitsett T. L. Cardiovascular effects of levodopa. JAMA. 1971 Dec 27;218(13):1921–1923. [PubMed] [Google Scholar]
- HOLMES J. C., FOWLER N. O. Direct cardiac effects of dopamine. Circ Res. 1962 Jan;10:68–72. doi: 10.1161/01.res.10.1.68. [DOI] [PubMed] [Google Scholar]
- HORWITZ D., FOX SM 3. D., GOLDBERG L. I. Effects of Dopamine in man. Circ Res. 1962 Feb;10:237–243. doi: 10.1161/01.res.10.2.237. [DOI] [PubMed] [Google Scholar]
- Hunter K. R., Hollman A., Laurence D. R., Stern G. M. Levodopa in Parkinsonian patients with heart-disease. Lancet. 1971 May 8;1(7706):932–934. doi: 10.1016/s0140-6736(71)91439-5. [DOI] [PubMed] [Google Scholar]
- Katz R. L., Lord C. O., Eakins K. E. Anesthetic-dopamine cardiac arrhythmias and their prevention by beta adrenergic blockade. J Pharmacol Exp Ther. 1967 Oct;158(1):40–45. [PubMed] [Google Scholar]
- Klawans H. L., Jr, Garvin J. S. Treatment of parkinsonism with L-dopa (study of 105 patients). Dis Nerv Syst. 1969 Nov;30(11):737–746. [PubMed] [Google Scholar]
- Mars H., Krall J. L-dopa and cardiac arrhythmias. N Engl J Med. 1971 Dec 16;285(25):1437–1437. doi: 10.1056/NEJM197112162852520. [DOI] [PubMed] [Google Scholar]
- Mawdsley C. Treatment of Parkinsonism with Laevo-dopa. Br Med J. 1970 Feb 7;1(5692):331–337. doi: 10.1136/bmj.1.5692.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McDowell F., Lee J. E., Swift T., Sweet R. D., Ogsbury J. S., Kessler J. T. Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa). Ann Intern Med. 1970 Jan;72(1):29–35. doi: 10.7326/0003-4819-72-1-29. [DOI] [PubMed] [Google Scholar]
- Mones R. J., Elizan T. S., Siegel G. J. Evaluation of L-dopa therapy in Parkinson's disease. N Y State J Med. 1970 Sep 15;70(18):2309–2318. [PubMed] [Google Scholar]
- Parks L. C., Watanabe A. M., Kopin I. J. Prevention or reversal of levodopa-induced cardiac arrhythmias by decarboxylase inhibitors. Lancet. 1970 Nov 14;2(7681):1014–1015. doi: 10.1016/s0140-6736(70)92818-7. [DOI] [PubMed] [Google Scholar]
- Yahr M. D., Duvoisin R. C., Hoehn M. M., Schear M. J., Barrett R. E. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism. Trans Am Neurol Assoc. 1968;93:56–63. [PubMed] [Google Scholar]
- Yahr M. D., Duvoisin R. C., Schear M. J., Barrett R. E., Hoehn M. M. Treatment of parkinsonism with levodopa. Arch Neurol. 1969 Oct;21(4):343–354. doi: 10.1001/archneur.1969.00480160015001. [DOI] [PubMed] [Google Scholar]
- Young A. C., Downie A. W. Parkinsonism and cardiac arrhythmias. Lancet. 1970 Dec 5;2(7684):1186–1186. doi: 10.1016/s0140-6736(70)90369-7. [DOI] [PubMed] [Google Scholar]
